Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1)
in the sixth column, expiration of approval, of row 309, Haloxyfop-P, the date is replaced by ‘31 December 2023’;
(2)
in the sixth column, expiration of approval, of row 310, Napropamide, the date is replaced by ‘31 December 2023’;
(3)
in the sixth column, expiration of approval, of row 318, Bromuconazole, the date is replaced by ‘31 January 2024’;
(4)
in the sixth column, expiration of approval, of row 320, Buprofezin, the date is replaced by ‘31 January 2023’.